Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 4 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.016. • Maintains antimicrobial activity when tested as demonstrated by a 7 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a zone of inhibition is maintained on day 7. Reference WI-8.2.4-2.013.
Efficacy. Except as specifically provided herein, this Amendment does not in any way waive, amend, modify, affect or impair the terms and conditions of the Purchase Agreement, and all terms and conditions of the Purchase Agreement are hereby ratified and confirmed and shall remain in full force and effect unless otherwise specifically amended, waived, modified or changed pursuant to the terms and conditions of this Amendment. All references in the Purchase Agreement to the term “this Agreement” shall be deemed to refer to the Purchase Agreement referenced in, and as amended by, this Amendment.
Efficacy a. Descriptive statistics for all primary and secondary endpoints
Efficacy. DURATION - CESSATION This contract is valid from to In case the event shall last longer, the present can be extended prior to written agreement among the parties. The event organizer shall communicate to the Agency the reasons for requesting the extension of the present contract. The Agency once assessed these reasons, can grant a time extension or can decide to resolve the present contract without any claim by the organizer. The Agency retains the right to terminate the contract for breach at any time, with the exception of the already completed activities, giving a notice of 30 (thirty) working days. This notice shall be communicated through registered letter.
Efficacy. The Products that result from the practice of the USGN Know-How or the USGN Patent Rights will effectively neutralize or decontaminate the biological and/or chemical substances as set forth in Exhibit C and are fit for the purpose of neutralizing or decontaminating such substances as set forth in Exhibit C.
Efficacy. This License Agreement is valid without Licensor’s signature. It becomes effective upon the Licensee’s first use of the Product.
Efficacy. 5.1 The present Memorandum of Understanding only requires the Parties to negotiate based on the terms and conditions described above. It does not determine any type of contract between the Parties.
Efficacy. 5.4.1. Survival Status The primary endpoint of the study is all-cause mortality, therefore the survival status of each subject will be noted at each visit. In the case of subjects who prematurely withdraw from study treatment survival status will be noted at 12-weekly intervals until 156 weeks have elapsed since the subject was randomised to study treatment. See Section 5.7.3 “Long-Term Follow-up of Subjects Withdrawn from Study Treatment”. All deaths occurring during the study treatment period and the long-term follow-up period should also be reported on the paper SAE form and faxed within 24 hours and the SAE entry section in the CRF completed. See Section 7 (AEs and SAEs). In addition, during the long-term follow-up study drug related SAEs should be reported on the paper SAE forms and faxed within 24 hours and the Survival Status Form completed. Accurate assignment of the cause of death is essential and should be done as follows:
Efficacy. Adopting an approach that strives for continuous improvement in the quality and cost of services provided to residents by using data to find efficiencies and adjusting to changing circumstances.
Efficacy. Arising out of the failure of a Product, or any part thereof, to fulfill the purpose for which it was intended, or to perform as specified, warranted, or guaranteed; but this Exception shall not apply to consequent Bodily Injury or loss of, or damage to, Property.
